Synairgen (SNG) Short Positions
Add to Alert list

Active Short Positions

Holder Position Change Date
No active short positions

Historical Short Positions

Holder Position Change (%) Date
Citadel Advisors LLC 0.42% 22-Feb-2022 View History
Citadel Advisors LLC 0.59% 21-Feb-2022 View History
Citadel Advisors LLC 0.48% 07-Dec-2021 View History
Citadel Advisors LLC 0.5% 06-Dec-2021 View History
Citadel Advisors LLC 0.39% 19-Jan-2021 View History
Citadel Advisors LLC 0.51% 14-Jan-2021 View History

Synairgen is a University spin-off and public limited company working in drug discovery and biotechnology. It was founded in 2003 by University of Southampton professors Stephen Holgate, Donna E. Davies and Ratko Djukanovic.

Synairgen is a specialist respiratory biotech company whose primary focus is developing our investigative inhaled interferon beta candidate (SNG001) for severe viral lung infections.

Synairgen share price launched at 155p in 2004.

Note: This description is in part generated by AI and not an endorsement by or the opinion of Investegate
UK 100

Latest directors dealings